The different immune status of peripheral blood and tumor tissue could also explain why the expression levels of the three genes in PBMCs have no correlation with the soluble PD-1 level, while in HCC, all of them were strongly associated with the mRNA expression of immune checkpoint molecules: PD-1, CTLA-4, and TIM-3. The gene discussed is CTLA4; the disease is neoplasm.